2008
DOI: 10.1016/j.jss.2007.07.023
|View full text |Cite|
|
Sign up to set email alerts
|

Acute Lung Injury in a Rat Model of Intestinal Ischemia-Reperfusion: The Potential Time Depended Role of Phospholipases A2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
31
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(34 citation statements)
references
References 40 publications
3
31
0
Order By: Relevance
“…Our findings implicated a critical role of TLR4 signaling in lung inflammatory injury triggered by intestinal I/R. Secondary lung inflammatory response plays a key role in the pathogenesis of acute lung injury in gut I/R [13][14][15], but the mechanisms of this process are poorly understood. Accumulation of neutrophils in the lung is a prominent feature of ALI after intestinal I/R [16].…”
Section: Discussionmentioning
confidence: 82%
“…Our findings implicated a critical role of TLR4 signaling in lung inflammatory injury triggered by intestinal I/R. Secondary lung inflammatory response plays a key role in the pathogenesis of acute lung injury in gut I/R [13][14][15], but the mechanisms of this process are poorly understood. Accumulation of neutrophils in the lung is a prominent feature of ALI after intestinal I/R [16].…”
Section: Discussionmentioning
confidence: 82%
“…Ischemia-reperfusion (I/R) injury is one of the main factors affecting the function and structure of SBT, by generation of proinflammatory mediators such as reactive oxygen species, reactive nitrogen species (e.g., NO), cytokines (e.g., TNF, IL-8). and endotoxin [2][3][4][5][6]. The generated cascade may activate leukocytes and endothelial cells, which ultimately lead to tissue inflammation, multiple organ dysfunction, and death [7].…”
Section: Introductionmentioning
confidence: 99%
“…Among the therapeutic modalities able to mitigate the harmful effects of local and remote I/R, there are the use of: antioxidants and anti-inflammatory medications (Kostopanagiotou et al 2007, Avgerinos et al 2010, Yurdakan et al 2012, use of propofol (Vasileiou et al 2012), green tea (Abdeen et al 2011), hydrocortisone (Alves et al 2011), rutin (Itagaki et al 2010), glutamine (Pagliosa et al 2009), methylene blue (Greca et al 2008), dimethyl sulfoxide (DMSO) (Dabareiner et al 2005), copaiba oils (Paiva et al 2004), among others.…”
Section: Introductionmentioning
confidence: 99%